Smoking Cessation and Nicotine De-addiction Market by Product and Geography - Forecast and Analysis 2021-2025

  • Published: Nov 2021
  • Pages: 120
  • SKU: IRTNTR40398
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The smoking cessation and nicotine de-addiction market share is expected to increase by USD 18.01 billion from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 11.59%.

This smoking cessation and nicotine de-addiction market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers smoking cessation and nicotine de-addiction market segmentation by product (e-cigarette, NRT, and drug therapy) and geography (North America, Europe, APAC, South America, and MEA). The smoking cessation and nicotine de-addiction market report also offers information on several market vendors, including British American Tobacco Plc, Cipla Inc., Dr. Reddys Laboratories Ltd., GlaxoSmithKline Plc, Imperial Brands Plc, Japan Tobacco Inc., Johnson and Johnson Inc., JUUL Labs Inc., Pfizer Inc., and Philip Morris International Inc. among others.

What will the Smoking Cessation & Nicotine De-addiction Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Smoking Cessation and Nicotine De-addiction Market Size for the Forecast Period and Other Important Statistics

 

Smoking Cessation & Nicotine De-addiction Market: Key Drivers and Trends

The new product launches are notably driving the smoking cessation and nicotine de-addiction market growth, although factors such as health issues associated with smoking cessation products may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the smoking cessation and nicotine de-addiction industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Smoking Cessation and Nicotine De-addiction Market Driver

One of the key factors driving growth in the smoking cessation and nicotine de-addiction market is the new product launches. The demand for smoking cessation aids is increasing globally, with a rise in the number of people trying to quit smoking. Vendors are coming up with new smoking cessation aids such as e-cigarette and nicotine patches to meet growing consumer demands. For instance, Kind Consumer Ltd. (Kind Consumer) announced the launch of its breath-activated Voke 0.45 mg nicotine inhaler in the UK market. The Voke inhaler was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for the relief or prevention of nicotine cravings and withdrawal symptoms. Also, GlaxoSmithKline Plc (GSK) launched new nicotine lozenges in the market. The new product, a coated ice mint lozenge, is marketed as a nicotine replacement product and is targeted at smokers who are trying to quit smoking

Key Smoking Cessation and Nicotine De-addiction Market Challenge

The health issues associated with smoking cessation products will be a major challenge for the smoking cessation and nicotine de-addiction market during the forecast period. Long-term use of nicotine gums can cause various health problems, such as hair loss, skin irritation, elevated blood pressure, irregular heartbeat, insulin resistance, gastrointestinal issues, and nausea. Also, people who use nicotine gums have a higher risk of heart palpitations and chest pain compared to normal people. Side effects of nicotine patches include skin irritation, itching, dizziness, and headache. Researchers have found that two primary ingredients found in e-cigarettes (propylene glycol and vegetable glycerin) are toxic to cells in the human body. E-cigarettes also produce dangerous chemicals such as acetaldehyde, acrolein, and formaldehyde, which can cause lung and cardiovascular diseases. These cigarettes contain acrolein, which can cause issues such as acute lung injury and chronic obstructive pulmonary disease (COPD).

This smoking cessation and nicotine de-addiction market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Who are the Major Smoking Cessation & Nicotine De-addiction Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • British American Tobacco Plc
  • Cipla Inc.
  • Dr. Reddys Laboratories Ltd.
  • GlaxoSmithKline Plc
  • Imperial Brands Plc
  • Japan Tobacco Inc.
  • Johnson and Johnson Inc.
  • JUUL Labs Inc.
  • Pfizer Inc.
  • Philip Morris International Inc.

 

This statistical study of the smoking cessation and nicotine de-addiction market encompasses successful business strategies deployed by the key vendors. The smoking cessation and nicotine de-addiction market is fragmented and the vendors are deploying growth strategies such as distinguishing their product offerings through clear and unique value propositions to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The smoking cessation and nicotine de-addiction market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Smoking Cessation & Nicotine De-addiction Market?

For more insights on the market share of various regions Request for a FREE sample now!

32% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for smoking cessation and nicotine de-addiction in North America. However, the market growth in this region will be slower than the growth of the market in the European, APAC, and MEA regions.

The growing awareness about the harmful effects of cigarette smoking and the increasing number of people trying to quit smoking will facilitate the smoking cessation and nicotine de-addiction market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Product Segments in the Smoking Cessation and Nicotine De-addiction Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The smoking cessation and nicotine de-addiction market share growth by the e-cigarette segment will be significant during the forecast period. Several vendors are focusing on reducing the nicotine content in their products to provide a safer alternative to customers. The introduction of new products and continuous product innovation by vendors will also boost the growth of the e-cigarette segment. Moreover, the relative safety of e-cigarettes, along with the launch of new products in the market, will drive the segment growth.

This report provides an accurate prediction of the contribution of all the segments to the growth of the smoking cessation and nicotine de-addiction market size and actionable market insights on post COVID-19 impact on each segment.

 

Smoking Cessation and Nicotine De-addiction Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 11.59%

Market growth 2021-2025

$ 18.01 billion

Market structure

Fragmented

YoY growth (%)

9.57

Regional analysis

North America, Europe, APAC, South America, and MEA

Performing market contribution

North America at 32%

Key consumer countries

US, Germany, China, Canada, and India

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

British American Tobacco Plc, Cipla Inc., Dr. Reddys Laboratories Ltd., GlaxoSmithKline Plc, Imperial Brands Plc, Japan Tobacco Inc., Johnson and Johnson Inc., JUUL Labs Inc., Pfizer Inc., and Philip Morris International Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Smoking Cessation & Nicotine De-addiction Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive smoking cessation and nicotine de-addiction market growth during the next five years
  • Precise estimation of the smoking cessation and nicotine de-addiction market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the smoking cessation and nicotine de-addiction industry across North America, Europe, APAC, South America, and MEA
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of smoking cessation and nicotine de-addiction market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Executive Summary

    Market Landscape

    • Market ecosystem
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025

    Five Forces Analysis

    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by Product

    • Market segments
    • Comparison by Product
    • E-cigarette - Market size and forecast 2020-2025
    • NRT - Market size and forecast 2020-2025
    • Drug therapy - Market size and forecast 2020-2025
    • Market opportunity by Product

    Customer landscape

      Geographic Landscape

      • Geographic segmentation
      • Geographic comparison
      • North America - Market size and forecast 2020-2025
      • Europe - Market size and forecast 2020-2025
      • APAC - Market size and forecast 2020-2025
      • South America - Market size and forecast 2020-2025
      • MEA - Market size and forecast 2020-2025
      • Key leading countries
      • Market opportunity by geography
      • Market drivers
      • Market challenges
      • Market trends

      Vendor Landscape

      • Overview
      • Vendor landscape
      • Landscape disruption

      Vendor Analysis

      • Vendors covered
      • Market positioning of vendors
      • British American Tobacco Plc
      • Cipla Inc.
      • Dr. Reddys Laboratories Ltd.
      • GlaxoSmithKline Plc
      • Imperial Brands Plc
      • Japan Tobacco Inc.
      • Johnson and Johnson Inc.
      • JUUL Labs Inc.
      • Pfizer Inc.
      • Philip Morris International Inc.

      Appendix

      • Scope of the report
      • Currency conversion rates for US$
      • Research methodology
      • List of abbreviations

      Research Framework

      Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

      TechnavioINFORMATION SOURCES

      Primary sources

      • Manufacturers and suppliers
      • Channel partners
      • Industry experts
      • Strategic decision makers

      Secondary sources

      • Industry journals and periodicals
      • Government data
      • Financial reports of key industry players
      • Historical data
      • Press releases
      Technavio

      TechnavioDATA ANALYSIS

      Data Synthesis

      • Collation of data
      • Estimation of key figures
      • Analysis of derived insights

      Data Validation

      • Triangulation with data models
      • Reference against proprietary databases
      • Corroboration with industry experts
      Technavio

      TechnavioREPORT WRITING

      Qualitative

      • Market drivers
      • Market challenges
      • Market trends
      • Five forces analysis

      Quantitative

      • Market size and forecast
      • Market segmentation
      • Geographical insights
      • Competitive landscape
      Interested in this report?
      Get your FREE sample now!
      The smoking cessation and nicotine de-addiction market growth will increase by $18011.94 million during 2020-2025.
      The smoking cessation and nicotine de-addiction market is expected to grow at a CAGR of 11.59% during 2020-2025.
      Technavio has segmented the smoking cessation and nicotine de-addiction market by product (E-cigarette, NRT, and Drug therapy) and geographic (North America, Europe, APAC, South America, and MEA).
      British American Tobacco Plc, Cipla Inc., Dr. Reddys Laboratories Ltd., GlaxoSmithKline Plc, Imperial Brands Plc, Japan Tobacco Inc., Johnson and Johnson Inc., JUUL Labs Inc., Pfizer Inc., Philip Morris International Inc. are a few of the key vendors in the smoking cessation and nicotine de-addiction market.
      North America will register the highest growth rate of 31.93% among the other regions. Therefore, the smoking cessation and nicotine de-addiction market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
      The key factors driving the smoking cessation and nicotine de-addiction market growth are:
      • New product launch
      • New marketing initiatives
      The smoking cessation and nicotine de-addiction market vendors should focus on grabbing business opportunities from the e-cigarette segment as it accounted for the largest market share in the base year.
      Safe and Secure SSL Encrypted
      Technavio

      Single User:

      2500 USD

      Technavio Get the report (PDF) sent to your email within minutes.

      Subscribe & Save

      Get lifetime access to our
      Technavio Insights

      Want to customize this report?

      This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

      We offer $1000 worth of FREE customization at the time of purchase
      Technavio
      Enquire Before Buying
      1. Home
      2. Health Care
      3. Published Report
      17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>